Rexahn Pharmaceuticals, Inc.. (RNN) NYSE American
$5.24 - (-)
Market Cap: $21.09M
As of 06/07/19 04:00 PM EDT. Market closed.
Rexahn Pharmaceuticals, Inc.. (RNN)
NYSE American
$5.24
- (-)
Market Cap: $21.09M
As of 06/07/19 04:00 PM EDT. Market closed.
Add to Portfolio
Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, ... read more
COMPANY PROFILE
Sector
Health Technology
Industry
Biotechnology
CEO
Douglas J. Swirsky
Full Time Employees
10
Sector
Health Technology
Industry
Biotechnology
CEO
Douglas J. Swirsky
Full Time Employees
10
URL
Address
15245 Shady Grove Road, MD, Rockville, 20850.
PRICE CHART FOR REXAHN PHARMACEUTICALS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
$4.71 - $23.64
Volume
0
Avg. Volume (30 days)
34,059
Market Cap
$21.09M
Dividend Yield
-
P/E
-
Shares Outstanding
4,024,000
Open
-
Previous Close
-
Days Range
- - -
52 week range
$4.71 - $23.64
Volume
0
Avg. Volume (30 days)
34,059
Market Cap
$21.09M
Dividend Yield
-
P/E
-
Shares Outstanding
4,024,000
FINANCIAL STATEMENTS FOR REXAHN PHARMACEUTICALS, INC.
LOADING...
INSIDER TRANSACTIONS FOR REXAHN PHARMACEUTICALS, INC.
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
SCHACHLE JOSEPH K | Chief Operating Officer | Mar 21, 2024 | Buy | $2.05 | 2,000 | 4,100 | 2,000 | Mar 25, 2024, 04:44 PM |
Jhaveri Nirav S. | Chief Financial Officer | Mar 21, 2024 | Buy | $2.10 | 10,000 | 21,000 | 150,000 | Mar 25, 2024, 04:40 PM |
Magrath George | Chief Executive Officer | Mar 18, 2024 | Buy | $1.96 | 25,000 | 49,050 | 425,000 | Mar 20, 2024, 04:18 PM |
Zaremba Rabourn Amy | SVP of Finance | Jan 10, 2024 | Option Exercise | $3.27 | 3,950 | 12,897 | 42,658 | Jan 12, 2024, 04:17 PM |
Patel Ronil A. | Chief Business Officer | Jan 10, 2024 | Option Exercise | $3.27 | 1,282 | 4,186 | 90,714 | Jan 12, 2024, 04:17 PM |
Hoffmann Bernhard | SVP of Corp. Dev. | Jan 10, 2024 | Option Exercise | $3.27 | 4,031 | 13,161 | 142,697 | Jan 12, 2024, 04:17 PM |
Gallagher Cam | Director | Jan 04, 2023 | Option Exercise | $0.00 | 1,574 | 0 | 24,928 | Jan 06, 2023, 09:00 AM |
Ainsworth Sean | Director | Oct 19, 2022 | Option Exercise | $0.00 | 1,574 | 0 | 41,239 | Oct 20, 2022, 04:01 PM |
MANUSO JAMES S J | Director | Oct 11, 2022 | Option Exercise | $0.00 | 787 | 0 | 36,465 | Oct 12, 2022, 04:23 PM |
Rodgers Richard J | Director | Oct 03, 2022 | Option Exercise | $0.00 | 3,148 | 0 | 67,424 | Oct 04, 2022, 09:00 AM |
Sooch Mina | President and CEO | Sep 06, 2022 | Option Exercise | $0.00 | 1,023 | 0 | 426,045 | Sep 08, 2022, 04:01 PM |
MANUSO JAMES S J | Director | May 20, 2022 | Buy | $1.99 | 5,000 | 9,950 | 21,570 | May 24, 2022, 09:43 AM |
Sooch Mina | President and CEO | May 20, 2022 | Buy | $2.02 | 12,500 | 25,300 | 425,022 | May 23, 2022, 04:58 PM |
Sooch Mina | President and CEO | May 19, 2022 | Buy | $2.07 | 12,500 | 25,879 | 412,522 | May 23, 2022, 04:58 PM |
Pepose Jay | Director | Dec 13, 2021 | Buy | $3.65 | 8,250 | 30,113 | 22,994 | Dec 14, 2021, 08:44 PM |
MANUSO JAMES S J | Director | Nov 18, 2021 | Buy | $3.50 | 2,000 | 7,000 | 16,570 | Nov 22, 2021, 04:01 PM |
Pepose Jay | Director | Sep 13, 2021 | Buy | $4.75 | 12,631 | 59,997 | 14,744 | Sep 15, 2021, 08:00 AM |
Benton Susan | Director | Sep 02, 2021 | Buy | $4.57 | 20,000 | 91,400 | 23,976 | Sep 03, 2021, 04:02 PM |
Beever Charles | Director | Jan 31, 2019 | Buy | $0.64 | 10,000 | 6,380 | 11,000 | Feb 04, 2019, 04:53 PM |
Price Ben Gil | Director | Jan 29, 2019 | Buy | $0.61 | 15,000 | 9,141 | 15,000 | Jan 31, 2019, 07:56 AM |
Nolan Lisa | Chief Business Officer | Jan 30, 2019 | Buy | $0.65 | 20,000 | 12,960 | 21,625 | Jan 31, 2019, 07:48 AM |
Swirsky Douglas J | President and CEO | Jan 29, 2019 | Buy | $0.63 | 50,000 | 31,720 | 50,000 | Jan 30, 2019, 07:32 AM |
Suzdak Peter David | Chief Executive Officer | Aug 16, 2017 | Option Exercise | $1.99 | 10,000 | 19,872 | 16,000 | Aug 16, 2017, 04:05 PM |
Ahn Chang Ho | Director | Apr 10, 2017 | Option Exercise | $0.31 | 250,000 | 77,500 | 6,260,000 | Apr 12, 2017, 05:26 PM |
Ahn Chang Ho | Director | Apr 10, 2017 | Sale | $0.70 | 250,000 | 175,375 | 6,010,000 | Apr 12, 2017, 05:26 PM |
Suzdak Peter David | Chief Executive Officer | Mar 18, 2016 | Option Exercise | $0.32 | 60,000 | 19,386 | 60,000 | Mar 21, 2016, 09:20 PM |
Jeong Tae Heum | Chief Financial Officer | Jan 09, 2015 | Option Exercise | $0.80 | 188,690 | 150,952 | 693,690 | Jan 12, 2015, 06:22 PM |
Jeong Tae Heum | Chief Financial Officer | Jan 08, 2015 | Option Exercise | $0.80 | 78,782 | 63,026 | 583,782 | Jan 12, 2015, 06:22 PM |
Jeong Tae Heum | Chief Financial Officer | Jan 12, 2015 | Option Exercise | $0.80 | 49,800 | 39,840 | 554,800 | Jan 12, 2015, 06:22 PM |
Jeong Tae Heum | Chief Financial Officer | Jan 08, 2015 | Sale | $0.90 | 78,782 | 70,935 | 505,000 | Jan 12, 2015, 06:22 PM |
Jeong Tae Heum | Chief Financial Officer | Jan 12, 2015 | Sale | $0.91 | 49,800 | 45,492 | 505,000 | Jan 12, 2015, 06:22 PM |
Jeong Tae Heum | Chief Financial Officer | Jan 09, 2015 | Sale | $0.92 | 188,690 | 172,708 | 505,000 | Jan 12, 2015, 06:22 PM |
Ahn Chang Ho | Director | Jan 09, 2015 | Option Exercise | $0.80 | 186,212 | 148,970 | 6,196,212 | Jan 12, 2015, 06:11 PM |
Ahn Chang Ho | Director | Jan 08, 2015 | Option Exercise | $0.80 | 80,000 | 64,000 | 6,090,000 | Jan 12, 2015, 06:11 PM |
Ahn Chang Ho | Director | Jan 12, 2015 | Option Exercise | $0.80 | 48,444 | 38,755 | 6,058,444 | Jan 12, 2015, 06:11 PM |
Ahn Chang Ho | Director | Jan 08, 2015 | Sale | $0.90 | 80,000 | 72,032 | 6,010,000 | Jan 12, 2015, 06:11 PM |
Ahn Chang Ho | Director | Jan 12, 2015 | Sale | $0.91 | 48,444 | 44,263 | 6,010,000 | Jan 12, 2015, 06:11 PM |
Ahn Chang Ho | Director | Jan 09, 2015 | Sale | $0.92 | 186,212 | 170,477 | 6,010,000 | Jan 12, 2015, 06:11 PM |
Ahn Chang Ho | Director | Jun 12, 2014 | Option Exercise | $0.80 | 136,193 | 108,954 | 6,950,117 | Jun 16, 2014, 07:48 PM |
Ahn Chang Ho | Director | Jun 12, 2014 | Sale | $0.99 | 136,193 | 134,436 | 6,813,924 | Jun 16, 2014, 07:48 PM |
McIntosh David M | Director | Apr 14, 2014 | Option Exercise | $1.01 | 99,010 | 100,000 | 25,990 | Apr 16, 2014, 04:18 PM |
McIntosh David M | Director | Apr 14, 2014 | Option Exercise | $0.80 | 125,000 | 100,000 | 125,000 | Apr 16, 2014, 04:18 PM |
Jeong Tae Heum | Chief Financial Officer | Sep 09, 2013 | Option Exercise | $0.46 | 78,861 | 36,000 | 576,139 | Sep 11, 2013, 06:01 PM |
Jeong Tae Heum | Chief Financial Officer | Sep 09, 2013 | Option Exercise | $0.24 | 150,000 | 36,000 | 655,000 | Sep 11, 2013, 06:01 PM |
Jeong Tae Heum | Chief Financial Officer | Sep 09, 2013 | Sale | $0.46 | 71,139 | 32,475 | 505,000 | Sep 11, 2013, 06:01 PM |
Kivel Richard | Director | Oct 03, 2011 | Buy | $1.04 | 2,500 | 2,600 | 2,500 | Oct 21, 2011, 04:41 PM |
Brandt Peter C. | Director | Sep 09, 2011 | Buy | $1.22 | 80,000 | 97,571 | 150,000 | Sep 12, 2011, 04:38 PM |
Brandt Peter C. | Director | Sep 08, 2011 | Buy | $1.10 | 45,000 | 49,284 | 70,000 | Sep 12, 2011, 04:38 PM |
Brandt Peter C. | Director | Sep 07, 2011 | Buy | $1.04 | 5,000 | 5,200 | 25,000 | Sep 08, 2011, 05:54 PM |
Brandt Peter C. | Director | Sep 06, 2011 | Buy | $0.95 | 20,000 | 18,923 | 20,000 | Sep 08, 2011, 05:54 PM |
Ahn Chang Ho | Chairman & CEO | May 18, 2011 | Buy | $1.31 | 1,008,078 | 1,320,582 | 11,338,924 | May 20, 2011, 04:30 PM |
Ahn Chang Ho | Chairman & CEO | Apr 01, 2011 | Buy | $1.22 | 320,846 | 391,432 | 10,330,846 | Apr 05, 2011, 05:00 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
SCHACHLE JOSEPH K | Chief Operating Officer | 03/21/2024 | 4,100 |
Jhaveri Nirav S. | Chief Financial Officer | 03/21/2024 | 21,000 |
Magrath George | Chief Executive Officer | 03/18/2024 | 49,050 |
Zaremba Rabourn Amy | SVP of Finance | 01/10/2024 | 12,897 |
Patel Ronil A. | Chief Business Officer | 01/10/2024 | 4,186 |
Hoffmann Bernhard | SVP of Corp. Dev. | 01/10/2024 | 13,161 |
Gallagher Cam | Director | 01/04/2023 | 0 |
Ainsworth Sean | Director | 10/19/2022 | 0 |
MANUSO JAMES S J | Director | 10/11/2022 | 0 |
Rodgers Richard J | Director | 10/03/2022 | 0 |
Sooch Mina | President and CEO | 09/06/2022 | 0 |
MANUSO JAMES S J | Director | 05/20/2022 | 9,950 |
Sooch Mina | President and CEO | 05/20/2022 | 25,300 |
Sooch Mina | President and CEO | 05/19/2022 | 25,879 |
Pepose Jay | Director | 12/13/2021 | 30,113 |
MANUSO JAMES S J | Director | 11/18/2021 | 7,000 |
Pepose Jay | Director | 09/13/2021 | 59,997 |
Benton Susan | Director | 09/02/2021 | 91,400 |
Beever Charles | Director | 01/31/2019 | 6,380 |
Price Ben Gil | Director | 01/29/2019 | 9,141 |
Nolan Lisa | Chief Business Officer | 01/30/2019 | 12,960 |
Swirsky Douglas J | President and CEO | 01/29/2019 | 31,720 |
Suzdak Peter David | Chief Executive Officer | 08/16/2017 | 19,872 |
Ahn Chang Ho | Director | 04/10/2017 | 77,500 |
Ahn Chang Ho | Director | 04/10/2017 | 175,375 |
Suzdak Peter David | Chief Executive Officer | 03/18/2016 | 19,386 |
Jeong Tae Heum | Chief Financial Officer | 01/09/2015 | 150,952 |
Jeong Tae Heum | Chief Financial Officer | 01/08/2015 | 63,026 |
Jeong Tae Heum | Chief Financial Officer | 01/12/2015 | 39,840 |
Jeong Tae Heum | Chief Financial Officer | 01/08/2015 | 70,935 |
Jeong Tae Heum | Chief Financial Officer | 01/12/2015 | 45,492 |
Jeong Tae Heum | Chief Financial Officer | 01/09/2015 | 172,708 |
Ahn Chang Ho | Director | 01/09/2015 | 148,970 |
Ahn Chang Ho | Director | 01/08/2015 | 64,000 |
Ahn Chang Ho | Director | 01/12/2015 | 38,755 |
Ahn Chang Ho | Director | 01/08/2015 | 72,032 |
Ahn Chang Ho | Director | 01/12/2015 | 44,263 |
Ahn Chang Ho | Director | 01/09/2015 | 170,477 |
Ahn Chang Ho | Director | 06/12/2014 | 108,954 |
Ahn Chang Ho | Director | 06/12/2014 | 134,436 |
McIntosh David M | Director | 04/14/2014 | 100,000 |
McIntosh David M | Director | 04/14/2014 | 100,000 |
Jeong Tae Heum | Chief Financial Officer | 09/09/2013 | 36,000 |
Jeong Tae Heum | Chief Financial Officer | 09/09/2013 | 36,000 |
Jeong Tae Heum | Chief Financial Officer | 09/09/2013 | 32,475 |
Kivel Richard | Director | 10/03/2011 | 2,600 |
Brandt Peter C. | Director | 09/09/2011 | 97,571 |
Brandt Peter C. | Director | 09/08/2011 | 49,284 |
Brandt Peter C. | Director | 09/07/2011 | 5,200 |
Brandt Peter C. | Director | 09/06/2011 | 18,923 |
Ahn Chang Ho | Chairman & CEO | 05/18/2011 | 1,320,582 |
Ahn Chang Ho | Chairman & CEO | 04/01/2011 | 391,432 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR REXAHN PHARMACEUTICALS, INC.
STOCK BUYBACKS FOR REXAHN PHARMACEUTICALS, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
2.69%
1Q
06/30/2023
9.77%
2Q
03/31/2023
9.88%
3Q
12/31/2022
-2.02%
4Q
09/30/2022
12.24%
5Q
06/30/2022
17.97%
6Q
03/31/2022
21.81%
7Q
12/31/2021
54.91%
8Q
09/30/2021
35.94%
9Q
06/30/2021
69.07%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR REXAHN PHARMACEUTICALS, INC.
LOADING...